Skip to content

Effects of Dexamethasone on the prevention of elevation of C-reactive protein and pain following laparoscopic cholecystectomy

Effects of Dexamethasone on the prevention of elevation of C-reactive protein and pain following laparoscopic cholecystectomy

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201012115364N1
Enrollment
68
Registered
2011-03-07
Start date
2010-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholelithiasis. Calculus of gallbladder without cholecystitis

Interventions

Intervention 1: 2cc intravenous normal saline. Intervention 2: 8 mg (2cc) intravenous dexametasone.
Placebo
Treatment - Drugs
2cc intravenous normal saline
8 mg (2cc) intravenous dexametasone

Sponsors

Vice Chancellor for Research & Technology Affairs
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients with diagnosis of cholelithiasis who are candidate for laparoscopic cholecystectomy. Exclusion criteria: pregnancy, age under 18 or over 80 years, body mass index over 30, presence of underlying disease, associated infection, history of previous abdominal surgery, diagnosis of empyema of gallbladder, usage of steroids and opioids during last week, and all situations which anesthetic drugs administration is contraindicated in, the selected cases will be enrolled after writing consent.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Pain intensity. Timepoint: 6 hours, 12 hours and 24 hours after surgery. Method of measurement: visual analog scale (VAS).;Serum Level of CRP. Timepoint: Before surgery and 6, 12 and 24 hours after surgery. Method of measurement: level of serum CRP with Elisa assay.

Secondary

MeasureTime frame
Amount of analgesic required. Timepoint: If the patient expressed pain. Method of measurement: miligram.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Khosrow Setaishy

Kermanshah University of Medical Sciences

k.setaishy@gmail.com+98 83 1427 6310

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026